| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 26, 2024 | BSX Boston Scientific Corp | Ludwig Edward J60 | Director | Sell | 9,818 | $73.29 | $719,562.20 | -19.2% | +1.5% | +39.3% | |
| Apr 26, 2024 | MASI Masimo Corp | Reynolds Craig B | Director | Sell | 40,000 | $136.17 | $5,446,616.00 | -84.4% | -19.4% | +20.3% | |
| Apr 26, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 872 | $1.07 | $931.58 | - | +8.8% | -30.2% | |
| Apr 24, 2024 | ATEC Alphatec Holdings, Inc. | Koning John Todd57 | Chief Financial Officer | Sell | 37,500 | $12.82 | $480,750.00 | -8.7% | -13.5% | -10.5% | |
| Apr 24, 2024 | NPCE Neuropace Inc | Orbimed Advisors LLC67 | 10% Owner | Sell | 1,781 | $14.06 | $25,040.86 | - | -37.6% | -17.0% | |
| Apr 23, 2024 | ISRG Intuitive Surgical Inc | Curet Myriam56 | EVP &Chief Medical Officer | Sell | 5,318 | $370.66 | $1,971,160.31 | -89.9% | +22.3% | +29.4% | |
| Apr 23, 2024 | ISRG Intuitive Surgical Inc | Levy Alan J50 | Director | Sell | 2,000 | $370.70 | $741,397.60 | -7.3% | +22.3% | +29.4% | |
| Apr 23, 2024 | NPCE Neuropace Inc | Orbimed Advisors LLC67 | 10% Owner | Sell | 64,653 | $14.12 | $913,056.90 | -0.6% | -45.4% | -22.1% | |
| Apr 22, 2024 | LUNG Pulmonx Corp | Rose Geoffrey Beran81 | Chief Commercial Officer | Sell | 1,184 | $7.49 | $8,868.16 | -0.4% | +13.0% | -35.7% | |
| Apr 22, 2024 | GCTK Glucotrack, Inc. | Sycoff Drew | Director, 10% Owner | Buy | 182,540 | $1.26 | $229,999.90 | +6.6% | -68.5% | -99.8% | |
| Apr 22, 2024 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 758 | $15.95 | $12,092.88 | -0.6% | +29.0% | +30.3% | |
| Apr 19, 2024 | CTKB Cytek Biosciences, Inc. | Yan Ming77 | Chief Technology Officer | Sell | 20,000 | $5.87 | $117,400.00 | -0.3% | +7.8% | -37.5% | |
| Apr 18, 2024 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 956 | $15.31 | $14,636.36 | -0.7% | +41.9% | +38.1% | |
| Apr 18, 2024 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 332 | $15.31 | $5,082.92 | -0.3% | +41.9% | +38.1% | |
| Apr 18, 2024 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality And Operations | Sell | 481 | $15.31 | $7,364.11 | -0.3% | +41.9% | +38.1% | |
| Apr 18, 2024 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 584 | $15.31 | $8,941.04 | -0.2% | +41.9% | +38.1% | |
| Apr 18, 2024 | NPCE Neuropace Inc | Orbimed Advisors LLC67 | 10% Owner | Sell | 16,992 | $14.02 | $238,231.07 | -0.2% | -46.4% | -22.9% | |
| Apr 17, 2024 | TMDX Transmedics Group, Inc. | Hassanein Waleed H56 | President &CEO | Sell | 4,000 | $95.12 | $380,480.00 | -5.1% | +72.8% | +0.4% | |
| Apr 17, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 15,363 | $1.03 | $15,800.85 | +0.1% | +13.5% | -32.9% | |
| Apr 17, 2024 | INSP Inspire Medical Systems, Inc. | Buchholz Richard73 | Chief Financial Officer | Sell | 15,000 | $230.03 | $3,450,450.00 | -34.7% | -40.1% | -38.3% | |
| Apr 17, 2024 | NEOG Neogen Corp | Jones Douglas Edward48 | Chief Operating Officer | Buy | 10,000 | $12.36 | $123,590.00 | +27.7% | +45.9% | -63.8% | |
| Apr 15, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 3,587 | $1.06 | $3,802.22 | - | +10.4% | -33.2% | |
| Apr 15, 2024 | SONX Sonendo, Inc. | Guo Chris | Interim CFO | Sell | 481 | $0.08 | $39.44 | -0.9% | - | - | |
| Apr 15, 2024 | PETV Petvivo Holdings, Inc. | Lai John | CEO And President | Buy | 150,000 | $0.60 | $90,000.00 | +13.2% | - | - | |
| Apr 15, 2024 | DXCM Dexcom Inc | Dolan Matthew Vincent63 | EVP Strategy And Corporate Dev | Sell | 1,990 | $137.81 | $274,241.90 | -4.5% | -16.0% | -48.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.